Tecan announces change in Management Board
Männedorf, Switzerland, March 26, 2020 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Markus Schmid, Head of Corporate Human Resources & Internal Communications and a member of the Group Management Board since 2011, will leave the company by no later than the end of April 2020. The search for a successor will be initiated.
Tecan's Board of Directors and CEO thank Markus Schmid for his strong engagement and valuable contribution to the development of Tecan and wish him all the best for the future.
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2019, Tecan generated sales of CHF 637 million (USD 643 million; EUR 574 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For further information:
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
FDA approves Roche’s Tecentriq in combination with Avastin for people with the most common form of liver cancer2.6.2020 07:00:00 CEST | Press release
Tecentriq in combination with Avastin is the first and only cancer immunotherapy regimen approved for the treatment of unresectable or metastatic hepatocellular carcinoma Tecentriq combination improved overall survival and progression-free survival compared to the previous standard of careApplication approved under FDA’s Project Orbis initiative and Real-Time Oncology Review pilot programme Basel, 2 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of people with unresectable or metastatic hepatocellular carcinoma (HCC) who have not received prior systemic therapy. “We’re excited that today’s approval of Tecentriq in combination with Avastin for unresectable or metastatic hepatocellular carcinoma brings a cancer immunotherapy option to people with this aggressive form of liver cancer,” said Levi Garraway, M.D., Ph.D., Chief Medi
EXEL INDUSTRIES :2019-2020 First-Half Results The initial benefits of our reorganization blacked out by the impact of the health crisis and depreciation of goodwill 1st semester 20191st semester 20202.6.2020 07:00:00 CEST | Press release
PRESS RELEASE Paris, June 2, 2020 2019-2020 First-Half Results The initial benefits of our reorganization blacked out by the impact of the health crisis and depreciation of goodwill 1st semester 20191st semester 2020in M€Oct 18 - Mar 19Oct 19 - Mar 20Revenue348.9314.3Current Operating Income5.0-1.1%1.4%-0.3%Non-recurring items-4.2-28.9Financial expenses-1.9-1.8(Losses)/gains on foreign exchange2.9-4.4Profit before tax1.7-36.2Tax expense-0.7-0.4Share of profit of associates0.20.2Net income 1.2-36.4 ·Analysis of 2019-2020 first-half results The decline in current operating income over the first-half of 2019-2020 was due primarily to the drop in revenue from Agricultural and Industrial Spraying due to the global health crisis. The reorganization initiated in 2019 produced visible results for the Sugar Beet Harvesting business. With respect to Agricultural Spraying, we expect an improvement by the end of the financial year. The very uncertain macro-economic context, notably as a result of
Mitsubishi Corporation and NTT complete acquisition of 30% stake in HERE Technologies2.6.2020 07:00:00 CEST | Press release
June 2, 2020 Amsterdam and Tokyo – HERE Technologies today announced that Mitsubishi Corporation (MC) and Nippon Telegraph and Telephone Corporation (NTT) of Japan have completed their joint acquisition of a 30% ownership stake in the company, after receiving regulatory approvals. HERE welcomes MC and NTT as strategic investors. The two companies have co-invested in HERE via their recently established, jointly owned holding company COCO Tech Holding B.V. in the Netherlands. As a result, HERE now has nine direct and indirect shareholders: Audi, Bosch, BMW Group, Continental, Intel Capital, MC, Mercedes-Benz, NTT and Pioneer. Following the transaction, HERE has added two new members to its Supervisory Board: Mr. Yutaka Kyoya, Executive Vice President, Group CEO, Consumer Industry Group, Mitsubishi Corporation; and Mr. Hiroki Kuriyama, Member of the Board, Executive Vice President, Head of Strategic Business Development, NTT. HERE’s broadened shareholder structure supports the company’s
Prosafe SE: Update on financial situation and process with lenders2.6.2020 07:00:00 CEST | Press release
Prosafe refers to the information on its financial status and process with lenders that has been provided over time and lastly in the Q1 2020 report published on 26 May 2020. The company has gained support to an extension to the previously reported forbearance arrangement with a majority of its lenders across its USD 1,300 million and USD 288 million facilities from end May 2020 till end June 2020. As part of this, the company will continue to defer making payments of scheduled instalments and interests under both facilities. Similarly, payment of the final instalment owed and due under the seller credit to Cosco for the Safe Notos remains as initially reported on 13 February subject to ongoing discussions with Cosco and the lenders. The company's discussions with its lenders remain constructive. The forbearance arrangement shows support for the company and creates stability to work with lenders to agree a long term financial solution, while lenders reserve their rights. Pending this,
EVS Broadcast Equipment reports update of share buyback program2.6.2020 06:45:00 CEST | Press release
Publication on June 2, 2020, before market opening Regulated information – reporting share buyback EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS reports update of share buyback program EVS Broadcast Equipment reports that the following transactions, conducted within the framework of the share buyback program announced on May 6, 2020, took place between May 25, 2020 and May 29, 2020. DateNumber of shares acquiredAverage price (EUR)Total (EUR)25/05/20202,500 13.7820 34,45526/05/20202,500 13.9834 34,95927/05/20202,500 14.2910 35,72828/05/20202,500 14.8076 37,01929/05/20202,500 14.4971 36,243Total12,50014.2722 178,403 As of May 29, 2020, and since the start of the buyback program, EVS has bought 27,267 shares at an average price of EUR 14,0123, representing in total EUR 382,072. After aforementioned transactions the total number of own shares amounts now to 618,319 shares as of May 29, 2020 (including 607,332 shares already held by the
Nexstim Abp: Preliminärt utfall av den lyckade företrädesemissionen1.6.2020 19:30:00 CEST | Pressemelding
Företagsmeddelande, insiderinformation, Helsingfors 1 juni 2020 kl. 20.30 (EEST) Nexstim Abp: Preliminärt utfall av den lyckade företrädesemissionen FÅR EJ PUBLICERAS ELLER SPRIDAS DIREKT ELLER INDIREKT I FÖRENTA STATERNA, AUSTRALIEN, SYDAFRIKA, HONGKONG, JAPAN, KANADA, SINGAPORE ELLER NÅGON ANNAN STAT DÄR SPRIDNINGEN ELLER PUBLICERINGEN STRIDER MOT LAGEN. Teckningstiden för Nexstim Abp:s (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”) företrädesemission om cirka 2,3 miljoner euro (”emissionen”) avslutades 25 maj 2020 i Sverige och 27 maj 2020 i Finland. Enligt det preliminära emissionsutfallet övertecknades emissionen och cirka 273 procent av de tilldelade aktierna tecknades. Av de tilldelade 376 719 780 nya aktierna (”emissionsaktierna”) tecknades 336 033 654 emissionsaktier (cirka 89,2 procent av emissionsaktierna) med företrädesrätt och 40 686 126 emissionsaktier (cirka 10,8 procent av emissionsaktierna) tilldelas i enlighet med emissionsvillkoren. Enligt det preliminära emissio